These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
68 related articles for article (PubMed ID: 346132)
1. Disappearance of prostacyclin (PGI2) in the circulation of the dog [proceedings]. Dusting GJ; Moncada S; Vane JR Br J Pharmacol; 1978 Mar; 62(3):414P-415P. PubMed ID: 346132 [No Abstract] [Full Text] [Related]
2. Recirculation of prostacyclin (PGI2) in the dog. Dusting GJ; Moncada S; Vane JR Br J Pharmacol; 1978 Oct; 64(2):315-20. PubMed ID: 361136 [TBL] [Abstract][Full Text] [Related]
3. Release of a prostacyclin-like substance into the circulation of dogs by intravenous adenosine 5'-diphosphate. Hemker DP; Shebuski RJ; Aiken JW J Pharmacol Exp Ther; 1980 Feb; 212(2):246-52. PubMed ID: 6985960 [No Abstract] [Full Text] [Related]
4. Circulating prostacyclin metabolites in the dog. Taylor BM; Shebuski RJ; Sun FF J Pharmacol Exp Ther; 1983 Mar; 224(3):692-8. PubMed ID: 6338207 [TBL] [Abstract][Full Text] [Related]
5. Differences in the stability of prostacyclin in human, rabbit and rat plasma. El Tahir KE; Williams KI; Betteridge DJ Prostaglandins Leukot Med; 1983 Feb; 10(2):109-14. PubMed ID: 6342001 [TBL] [Abstract][Full Text] [Related]
6. Prostacyclin is produced in whole blood [proceedings]. Blackwell GJ; Flower RJ; Russell-Smith N; Salmon JA; Thorogood PB; Vane JR Br J Pharmacol; 1978 Nov; 64(3):436P. PubMed ID: 363208 [No Abstract] [Full Text] [Related]
7. Prostacyclin-release by bradykinin in vivo [proceedings]. Moncada S; Mullane KM; Vane JR Br J Pharmacol; 1979 May; 66(1):96P-97P. PubMed ID: 378310 [No Abstract] [Full Text] [Related]
8. [Physiological significance of PGI2 (prostacyclin) in fetal circulating blood]. Matsumoto T; Kihira M; Ito M; Sugiyama Y Nihon Sanka Fujinka Gakkai Zasshi; 1982 Nov; 34(11):1919-20. PubMed ID: 6757341 [No Abstract] [Full Text] [Related]
9. Low doses of prostaglandin F2alpha (PGF2alpha) stimulate prostacyclin (PGI2) production in the mesenteric circulation of the PIG. Schrauwen E; Beetens J; Korteweg M Prostaglandins Med; 1979 Aug; 3(2):95-6. PubMed ID: 399531 [No Abstract] [Full Text] [Related]
10. Inactivation of prostacyclin (PGI2) by erythrocytes. Jakubowski JA; Thompson CB; Deykin D Br J Haematol; 1983 Aug; 54(4):658-60. PubMed ID: 6347244 [No Abstract] [Full Text] [Related]
11. Angiotensin-induced release of prostacyclin (PGI2) into circulation of anaesthetized cats. Swies J; Radomski M; Gryglewski RJ Pharmacol Res Commun; 1979 Sep; 11(8):649-55. PubMed ID: 390552 [No Abstract] [Full Text] [Related]
12. Stability of prostaglandin I2 in human blood. Pifer DD; Cagen LM; Chesney CM Prostaglandins; 1981 Feb; 21(2):165-75. PubMed ID: 7012932 [TBL] [Abstract][Full Text] [Related]
13. Prostacyclin release induced by bradykinin may contribute to the antihypertensive action of angiotensin-converting enzyme inhibitors. Mullane KM; Moncada S; Vane JR Adv Prostaglandin Thromboxane Res; 1980; 7():1159-61. PubMed ID: 6245567 [No Abstract] [Full Text] [Related]
14. Binding and inactivation of prostacyclin (PGI2) by human erythrocytes. Willems C; Stel HV; van Aken WG; van Mourik JA Br J Haematol; 1983 May; 54(1):43-52. PubMed ID: 6342654 [No Abstract] [Full Text] [Related]
15. Decreased vascular prostacyclin (PGI2) in diabetic rats. Stimulation of PGI2 release in normal and diabetic rats by the antithrombotic compound Bay g 6575. Carreras LO; Chamone DA; Klerckx P; Vermylen J Thromb Res; 1980 Aug 15-Sep 1; 19(4-5):663-70. PubMed ID: 7003804 [No Abstract] [Full Text] [Related]